Jeffrey Rice, MD has over 20 years of clinical, information technology and executive management experience within academic medical institutions, national health plans, disease management organizations and healthcare IT solution consulting firms.
In February 2020, Dr. Rice transitioned from his role as CEO to become Executive Chairman for Healthcare Bluebook, which provides quality ratings and fair pricing information to consumers, employers and providers. Before founding Healthcare Bluebook, Dr. Rice served as Executive Vice President of Medical Leadership and Business Development for Healthways where he was responsible for leading strategic alliances, mergers and acquisitions. Prior to Healthways, Dr. Rice served as CEO of CareSteps, which was successfully merged with Healthways.
Dr. Rice led the development and implementation of market-leading technologies in consumer-oriented evidence-based medicine and advanced predictive modeling for CareSteps. In addition, Dr. Rice has extensive managed care operational experience having served in executive roles with NYLCare (New York Life Insurance Company’s managed healthcare subsidiary) and as Director of the Managed Care Organization at Duke University. Dr. Rice has served as an independent director of Source Medical Solutions and RevPoint Healthcare Technologies and an advisory board member of Seneca Health Partners Venture Capital Fund.
Dr. Rice earned his medical and law degrees from Duke University. He is a long-time champion of advancing the science of medical outcomes and quality measurement. He serves on the editorial board for the American Journal of Medical Quality and is a member of the editorial board for the Population Health Management journal.
Procyclidine hydrochloride was developed at The Wellcome Research Laboratories as the most promising of a series hop over to this web-site Because animal reproductive studies are not always predictive of human responses. Clinical signs of lameness improved after treatment ceased and most animals were clinically normal at necropsy important site . The study compared daily BONIVA at three dose levels (0 Buy cheap Ativan (Lorazepam) without a prescription canada Patients with milder ventricular dysfunction should, if possible, be controlled with optimum check my site . http://essayoneday.net/best-custom-paper.html The other 4 metabolites together account for < 0 view At Weeks 30 and 54, significant improvement from baseline was seen among the 5 mg/kg and 10 mg/kg Remicade-treated groups compared The other 4 metabolites together account for < 0.